Middle East Tumor Marker Sales Segment Forecasts for over 40 Tests, 2019: An 11-Country Analysis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 7, 2020--
The “Middle East Tumor Marker Sales Segment Forecasts for over 40 Tests: An 11-Country Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities” report has been added to ResearchAndMarkets.com’s offering.
This new 11-country report from the author is available by country, market segment, section, or individual test.
This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.
The report provides granular market segmentation analysis and forecasts for over 40 tumor markers; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current and emerging assays; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and growth strategies for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
Business Opportunities and Strategic Recommendations
Over 200 Current and Emerging Cancer Diagnostic Tests
The companies analyzed in the report include:
For more information about this report visit https://www.researchandmarkets.com/r/6r5ogk
View source version on businesswire.com:https://www.businesswire.com/news/home/20200107005510/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: MIDDLE EAST
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 01/07/2020 06:07 AM/DISC: 01/07/2020 06:07 AM